Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1083573rdf:typepubmed:Citationlld:pubmed
pubmed-article:1083573lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:1083573lifeskim:mentionsumls-concept:C1882867lld:lifeskim
pubmed-article:1083573lifeskim:mentionsumls-concept:C0041964lld:lifeskim
pubmed-article:1083573lifeskim:mentionsumls-concept:C0040223lld:lifeskim
pubmed-article:1083573lifeskim:mentionsumls-concept:C1518062lld:lifeskim
pubmed-article:1083573pubmed:issue4lld:pubmed
pubmed-article:1083573pubmed:dateCreated1976-7-6lld:pubmed
pubmed-article:1083573pubmed:abstractTextThe effect of urethan on various spleen-lymphocyte functions was studied in the rat for 45 days after administration of the carcinogen. For 3 days following the last injection of urethan, the total cell number and LPS reactivity were greatly reduced. Certain reactivities, probably T-cell dependent functions, such as responsiveness to the in vitro mitogenic effect of PHA, Con A, and primary stimulation by histocompatibility alloantigens in the one-way reaction, were selectively enriched during the first 2 days. Thereafter several dissociations of these lymphocyte functions can be observed: i.e., various intervals succeed during which one function may be enriched and other(s) diminished. It seems that the kinetics of enrichment, decay and recovery of the T-cell subsets involved in the reactions investigated follow a distinctive profile for each one of them. It is suggested, as a working hypothesis, that the unbalanced situations derived from the time-course discordance of the quantitative changes in the various lymphocyte functions may allow, or even enhance, tumor development.lld:pubmed
pubmed-article:1083573pubmed:languageenglld:pubmed
pubmed-article:1083573pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1083573pubmed:citationSubsetIMlld:pubmed
pubmed-article:1083573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1083573pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1083573pubmed:statusMEDLINElld:pubmed
pubmed-article:1083573pubmed:issn0300-8916lld:pubmed
pubmed-article:1083573pubmed:authorpubmed-author:ProdiGGlld:pubmed
pubmed-article:1083573pubmed:authorpubmed-author:XerriLLlld:pubmed
pubmed-article:1083573pubmed:authorpubmed-author:Di MarcoA TATlld:pubmed
pubmed-article:1083573pubmed:authorpubmed-author:MacarioAAlld:pubmed
pubmed-article:1083573pubmed:issnTypePrintlld:pubmed
pubmed-article:1083573pubmed:volume61lld:pubmed
pubmed-article:1083573pubmed:ownerNLMlld:pubmed
pubmed-article:1083573pubmed:authorsCompleteYlld:pubmed
pubmed-article:1083573pubmed:pagination319-26lld:pubmed
pubmed-article:1083573pubmed:dateRevised2008-12-12lld:pubmed
pubmed-article:1083573pubmed:meshHeadingpubmed-meshheading:1083573-...lld:pubmed
pubmed-article:1083573pubmed:meshHeadingpubmed-meshheading:1083573-...lld:pubmed
pubmed-article:1083573pubmed:meshHeadingpubmed-meshheading:1083573-...lld:pubmed
pubmed-article:1083573pubmed:meshHeadingpubmed-meshheading:1083573-...lld:pubmed
pubmed-article:1083573pubmed:meshHeadingpubmed-meshheading:1083573-...lld:pubmed
pubmed-article:1083573pubmed:meshHeadingpubmed-meshheading:1083573-...lld:pubmed
pubmed-article:1083573pubmed:meshHeadingpubmed-meshheading:1083573-...lld:pubmed
pubmed-article:1083573pubmed:meshHeadingpubmed-meshheading:1083573-...lld:pubmed
pubmed-article:1083573pubmed:meshHeadingpubmed-meshheading:1083573-...lld:pubmed
pubmed-article:1083573pubmed:meshHeadingpubmed-meshheading:1083573-...lld:pubmed
pubmed-article:1083573pubmed:articleTitleLymphocyte functions in the rat spleen at various times after urethan administration.lld:pubmed
pubmed-article:1083573pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1083573lld:pubmed